GDF15 and metastatic malignant neoplasm in the lymph nodes: Collectively, high levels of GDF-15 are positively linked to poor prognosis in patients with NSCLC, manifesting as shorter overall survival (34), higher risk of lymph node metastasis (21), and higher recurrence rates (30).